Natco Pharma (Canada) Inc.

Natco Pharma (Canada) Inc. company information, Employees & Contact Information

Updated June 2026

Quick answer

Natco Pharma (Canada) Inc. is a Pharmaceutical Manufacturing company and founded in 2012. It has approximately 42 employees on record. Contact data was last refreshed in June 2026. Find Natco Pharma (Canada) Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Natco Pharma (Canada) Inc. is the Canadian subsidiary of Natco Pharma Limited. We are a vertically integrated pharmaceutical company focused on R&D and the manufacturing of drug products. NATCO is a trusted supplier of medicines evidenced from our work with the world’s largest drug companies. NATCO prioritizes trust and reliability in our products and services – That is our Canadian commitment.

Company Details

Employees
42
Founded
2012
Address
2000 Argentia Rd, Suite 200,plaza 1,canada
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Pharmaceuticals.
HQ
Mississauga, Ontario
Looking for a particular Natco Pharma (Canada) Inc. employee's phone or email?

Natco Pharma (Canada) Inc. Questions

News

Insiders At NATCO Pharma Sold ₹69m In Stock, Alluding To Potential Weakness - simplywall.st

Insiders At NATCO Pharma Sold ₹69m In Stock, Alluding To Potential Weakness simplywall.st

Natco Pharma sues Novo Nordisk in generic drug push - The Economic Times

Natco Pharma sues Novo Nordisk in generic drug push The Economic Times

Natco Pharma mulls demerger of agro business - The Hindu

Natco Pharma mulls demerger of agro business The Hindu

NATCO Pharma Shares Plummet 19% Post Q3 Results Amid Sharp Revenue and Profit Decline -Should You Buy? - Times Now

NATCO Pharma Shares Plummet 19% Post Q3 Results Amid Sharp Revenue and Profit Decline -Should You Buy? Times Now

Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds - CNBC TV18

Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds CNBC TV18

Natco Pharma shares tank 19%, near 52-week low on weak Q3 results - Business Standard

Natco Pharma shares tank 19%, near 52-week low on weak Q3 results Business Standard

U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad - The Hindu

U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad The Hindu

NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis - Medical Dialogues

NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis Medical Dialogues

Natco Pharma Canada arm invests $8 mln in eGenesis - Business Standard

Natco Pharma Canada arm invests $8 mln in eGenesis Business Standard

Natco Pharma Shares Up 3% After Settling US Patent Litigation on Generic Ozempic - Equitypandit

Natco Pharma Shares Up 3% After Settling US Patent Litigation on Generic Ozempic Equitypandit

Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada - Medical Dialogues

Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Medical Dialogues

Natco Pharma gains 3% on $8 million investment in US biotech firm eGenesis - CNBC TV18

Natco Pharma gains 3% on $8 million investment in US biotech firm eGenesis CNBC TV18

Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20 - Medical Buyer

Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20 Medical Buyer

Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic - CNBC TV18

Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic CNBC TV18

Natco Pharma announces resignation of Sourav Chakraborty, Associate Vice President - Sales & Marketing,... - Medical Dialogues

Natco Pharma announces resignation of Sourav Chakraborty, Associate Vice President - Sales & Marketing,... Medical Dialogues

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis - Business Standard

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis Business Standard

Natco arm, Celgene to settle dispute on cancer drug in Canada - The Hindu

Natco arm, Celgene to settle dispute on cancer drug in Canada The Hindu

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada - Business Standard

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada Business Standard

Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada - CNBC TV18

Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada CNBC TV18

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib - Business Standard

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib Business Standard

Polycab, Natco Pharma, Bikaji Foods & Gujarat Alkalies: 4 stock picks by SMC Global - Business Today

Polycab, Natco Pharma, Bikaji Foods & Gujarat Alkalies: 4 stock picks by SMC Global Business Today

Natco Pharma bullish on India, Brazil, Canada biz for FY20 - Zee Business

Natco Pharma bullish on India, Brazil, Canada biz for FY20 Zee Business

Natco Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Natco Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Natco Pharma (Canada) Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant